AAIC 2017: Alzheimer’s Association announces $20 million US lifestyle intervention study

Written by Francesca Lake

The Alzheimer’s Association has announced a US $20 million 2-year clinical trial aimed at discovering whether a lifestyle intervention can prevent cognitive decline and dementia. The announcement was made at the Alzheimer’s Association International Conference (AAIC; 16–20 July 2017) in London, UK. The trial, named US POINTER, will begin recruiting 2500 60–79-year-old patients in 2018. The patients will have no cognitive symptoms but will have an increased risk for cognitive decline (e.g., hypertension or elevated blood sugar). A combination of physical exercise, nutritional counselling and modification, cognitive and social stimulation and improved self-management of medical conditions will be used. Follow-up...

To view the full article, please register now for access

It's completely free